2007
DOI: 10.1164/rccm.200611-1653up
|View full text |Cite
|
Sign up to set email alerts
|

Update in Tuberculosis 2006

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
4
0
1

Year Published

2007
2007
2011
2011

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 16 publications
(5 citation statements)
references
References 51 publications
0
4
0
1
Order By: Relevance
“…T cell IFN-c release assays (TIGRA) are more specific and sensitive diagnostic tools for MTB infection than the tuberculin skin test (TST) [26,27,28]. TIGRA measures IFN-c production by mononuclear cells following stimulation with restricted antigens that are absent from BCG or most non-tuberculous Mycobacteria (NTM) [1].…”
Section: Discussionmentioning
confidence: 99%
“…T cell IFN-c release assays (TIGRA) are more specific and sensitive diagnostic tools for MTB infection than the tuberculin skin test (TST) [26,27,28]. TIGRA measures IFN-c production by mononuclear cells following stimulation with restricted antigens that are absent from BCG or most non-tuberculous Mycobacteria (NTM) [1].…”
Section: Discussionmentioning
confidence: 99%
“…CD4 1 CD25 high regulatory T cells are thought to modify this process and are increased in number. 16,18 The transcription factor FoxP3 helps to upregulate the numbers of CD25 and cytotoxic T lymphocyte-associated antigen 4 receptors on T regulatory cells. It has been reported that FoxP3 mRNA expression is increased, which is consistent with T regulatory cell suppression or modification of the T H 1 response in tuberculosis.…”
Section: Granulomatous T H 1 Inflammatory Conditionsmentioning
confidence: 99%
“…It has been reported that FoxP3 mRNA expression is increased, which is consistent with T regulatory cell suppression or modification of the T H 1 response in tuberculosis. 16,18 …”
Section: Granulomatous T H 1 Inflammatory Conditionsmentioning
confidence: 99%
“…TIGRA have been compared to the TST in a number of studies and proven to be superior to the TST in terms of sensitivity (TST 55%-74%, TIGRA 83%-97%) and specificity (TST 56%-98%, TIGRA 92%-100%) [2][3][4]. The advantages of the new tests are the availability of the test result within 24 h independent of a patient return visit, the absence of any influence of prior BCG vaccination, and a lower cross reactivity in cases of NTM infections.…”
Section: T Cell Interferon-c Release Assaysmentioning
confidence: 99%